Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Pediatrics

Genetic variations in adiponectin levels and dietary patterns on metabolic health among children with normal weight versus obesity: the BCAMS study

Abstract

Background/objectives

Adiponectin represents an important link between adipose tissue dysfunction and cardiometabolic risk in obesity; however, there is a lack of data on the effects of adiponectin-related genetic variations and gene-diet interactions on metabolic disorders in children. We aimed to investigate possible interactions between adiponectin-related genetic variants and habitual dietary patterns on metabolic health among children with normal weight versus overweight/obesity, and whether these effects in childhood longitudinally contribute to metabolic risk at follow-up.

Subjects/methods

In total, 3,317 Chinese children aged 6–18 at baseline and 339 participants at 10-year follow-up from the Beijing Child and Adolescent Metabolic Syndrome study cohort were included. Baseline lifestyle factors, plasma adiponectin levels, and six adiponectin-related genetic variants resulting from GWAS in East Asians (loci in/near ADIPOQ, CDH13, WDR11FGF, CMIP, and PEPD) were assessed for their associations with the metabolic disorders. Being metabolically unhealthy was defined by exhibiting any metabolic syndrome component.

Results

Among the six loci, ADIPOQ rs6773957 (OR 1.26, 95% CI:1.07–1.47, P = 0.004) and adiponectin receptor CDH13 rs4783244 (0.82, 0.69–0.96, P = 0.017) were correlated with metabolic risks independent of lifestyle factors in normal-weight children, but the associations were less obvious in those with overweight/obesity. A significant interaction between rs6773957 and diet (Pinteraction = 0.004) for metabolic health was observed in normal-weight children. The adiponectin-decreasing allele of rs6773957 was associated with greater metabolic risks in individuals with unfavorable diet patterns (P < 0.001), but not in those with healthy patterns (P > 0.1). A similar interaction effect was observed using longitudinal data (Pinteraction = 0.029).

Conclusions

These findings highlight a novel gene-diet interaction on the susceptibility to cardiometabolic disorders, which has a long-term impact from childhood onward, particularly in those with normal weight. Personalized dietary advice in these individuals may be recommended as an early possible therapeutic measure to improve metabolic health.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The ADIPOQ-diet interaction on metabolic health in normal weight children.
Fig. 2: The ADIPOQ-diet interaction on metabolic health after a 10-year follow-up.

Data availability

All datasets used in the current investigation are available from the corresponding author upon reasonable request.

Code availability

The code supporting the conclusions of this article is available upon a reasonable request from the authors.

References

  1. Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. The. New England journal of medicine. 2017;377:13–27.

    Article  Google Scholar 

  2. Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Annals of the New York Academy of Sciences. 2017;1391:85–100.

    Article  PubMed  Google Scholar 

  3. Samocha-Bonet D, Dixit VD, Kahn CR, Leibel RL, Lin X, Nieuwdorp M, et al. Metabolically healthy and unhealthy obese–the 2013 Stock Conference report. Obes Rev. 2014;15:697–708.

  4. Schulze MB. Metabolic health in normal-weight and obese individuals. Diabetologia. 2019;62:558–66.

    Article  PubMed  Google Scholar 

  5. Park JM, Park DH, Song Y, Kim JO, Choi JE, Kwon YJ, et al. Understanding the genetic architecture of the metabolically unhealthy normal weight and metabolically healthy obese phenotypes in a Korean population. Sci Rep. 2021;11:2279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23:770–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol. 2010;176:1364–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149:307–16.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D’Agostino RB Sr., Wilson PW, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. The Journal of clinical endocrinology and metabolism. 2008;93:3165–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.

    Article  CAS  PubMed  Google Scholar 

  11. Ahl S, Guenther M, Zhao S, James R, Marks J, Szabo A, et al. Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals. J Clin Endocrinol Metab. 2015;100:4172–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fu J, Li Y, Esangbedo IC, Li G, Feng D, Li L, et al. Circulating osteonectin and adipokine profiles in relation to metabolically healthy obesity in Chinese children: findings From BCAMS. Journal of the American Heart Association. 2018;7:e009169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011;60:2417–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8:e1002607.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ling H, Waterworth DM, Stirnadel HA, Pollin TI, Barter PJ, Kesäniemi YA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009;17:737–44.

    Article  CAS  Google Scholar 

  16. Wu Y, Gao H, Li H, Tabara Y, Nakatochi M, Chiu YF, et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet. 2014;23:1108–19.

    Article  CAS  PubMed  Google Scholar 

  17. Gao H, Fall T, Fau-van Dam RM, van Dam Rm Fau-Flyvbjerg A, Flyvbjerg A, Fau-Zethelius B, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes. 2013;62:1338–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ortega Moreno L, Copetti M, Fontana A, De Bonis C, Salvemini L, Trischitta V, et al. Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes. Cardiovascular diabetology. 2016;15:17.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Borges MC, Barros AJD, Ferreira DLS, Casas JP, Horta BL, Kivimaki M, et al. Metabolic profiling of adiponectin levels in adults: mendelian randomization analysis. Circ Cardiovasc Genet. 2017;10:e001837.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Au Yeung SL, Schooling CM. Adiponectin and coronary artery disease risk: a bi-directional Mendelian randomization study. International journal of cardiology. 2018;268:222–6.

    Article  PubMed  Google Scholar 

  21. Yaghootkar H, Lamina C, Scott RA, Dastani Z, Hivert MF, Warren LL, et al. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 2013;62:3589–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Borges MC, Lawlor DA, de Oliveira C, White J, Horta BL, Barros AJ. Role of adiponectin in coronary heart disease risk: a mendelian randomization study. Circ Res. 2016;119:491–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ma W, Huang T, Zheng Y, Wang M, Bray GA, Sacks FM, et al. Weight-loss diets, adiponectin, and changes in cardiometabolic risk in the 2-year POUNDS lost trial. The Journal of clinical endocrinology and metabolism. 2016;101:2415–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Varady KA, Hellerstein MK. Do calorie restriction or alternate-day fasting regimens modulate adipose tissue physiology in a way that reduces chronic disease risk? Nutr Rev. 2008;66:333–42.

    Article  PubMed  Google Scholar 

  25. AlEssa HB, Malik VS, Yuan C, Willett WC, Huang T, Hu FB, et al. Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women. The American journal of clinical nutrition. 2017;105:432–41.

    Article  CAS  PubMed  Google Scholar 

  26. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. International journal of obesity. 2009;33:424–39.

    Article  PubMed  Google Scholar 

  27. Li G, Esangbedo IC, Xu L, Fu J, Li L, Feng D, et al. Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study. Cardiovascular diabetology. 2018;17:69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fu J, Han L, Zhao Y, Li G, Zhu Y, Li Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS study. Clinical nutrition (Edinburgh, Scotland). 2019;38:2161–7.

    Article  CAS  Google Scholar 

  29. Li G, Yin J, Fu J, Li L, Grant SFA, Li C, et al. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study. Diabetes & metabolism. 2017;43:253–60.

    Article  CAS  Google Scholar 

  30. Force GOCO. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. China J Epidemiol. 2004;25:97–102.

    Google Scholar 

  31. Wa M, Jm T Puberty. In: F F, Jm T, editors. Human Growth. New York: Plenum Press; 1986. p. 171–210.

  32. Li M, Wu C, Song A, K Z. Development and preliminary application of enzyme-linked immunosorbent assay for human net insulin in serum. Chin J Endocrinol Metab. 1997;13:214–17.

    CAS  Google Scholar 

  33. Li Q, Lu Y, Sun L, Yan J, Yan X, Fang L, et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metabolism: clinical and experimental. 2012;61:1803–8.

    Article  CAS  Google Scholar 

  34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

    Article  CAS  PubMed  Google Scholar 

  35. Li L, Yin J, Cheng H, Wang Y, Gao S, Li M, et al. Identification of genetic and environmental factors predicting metabolically healthy obesity in children: data from the BCAMS study. J Clin Endocrinol Metab. 2016;101:1816–25.

    Article  CAS  PubMed  Google Scholar 

  36. Li L, Fu J, Yu XT, Li G, Xu L, Yin J, et al. Sleep duration and cardiometabolic risk among Chinese school-aged children: do adipokines play a mediating role? Sleep. 2017;40:zsx042.

  37. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr protoc in human genet. 2009; Chapter 2:Unit 2.12.

  38. Fu J, Hou C, Li L, Feng D, Li G, Li M, et al. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome. Cardiovascular diabetology. 2016;15:142.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  40. Goto A, Noda M, Goto M, Yasuda K, Mizoue T, Yamaji T, et al. Plasma adiponectin levels, ADIPOQ variants, and incidence of type 2 diabetes: A nested case-control study. Diabetes research and clinical practice. 2017;127:254–64.

    Article  CAS  PubMed  Google Scholar 

  41. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes. 2005;54:1607–10.

    Article  CAS  PubMed  Google Scholar 

  42. Patel S, Flyvbjerg A, Kozakova M, Frystyk J, Ibrahim IM, Petrie JR, et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. European heart journal. 2008;29:386–93.

    Article  CAS  PubMed  Google Scholar 

  43. Chen J-M, Férec C, Cooper DN. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Human Genetics. 2006;120:1–21.

    Article  CAS  PubMed  Google Scholar 

  44. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, et al. Systematic discovery of regulatory motifs in human promoters and 3’ UTRs by comparison of several mammals. Nature. 2005;434:338–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Vishvanath L, Gupta RK. Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest. 2019;129:4022–31.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Johannsen DL, Tchoukalova Y, Tam CS, Covington JD, Xie W, Schwarz JM, et al. Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the “adipose tissue expandability” hypothesis. Diabetes Care. 2014;37:2789–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Gao H, Kim YM, Chen P, Igase M, Kawamoto R, Kim MK, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes. 2013;62:4277–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. The Journal of clinical investigation. 2010;120:4342–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Keaton JM, Gao C, Guan M, Hellwege JN, Palmer ND, Pankow JS, et al. Genome-wide interaction with the insulin secretion locus MTNR1B reveals CMIP as a novel type 2 diabetes susceptibility gene in African Americans. Genet Epidemiol. 2018;42:559–70.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Dhurandhar NV, Schoeller D, Brown AW, Heymsfield SB, Thomas D, Sørensen TI, et al. Energy balance measurement: when something is not better than nothing. International journal of obesity. 2015;39:1109–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Jie Mi, the professor of Capital Institute of Pediatrics in Beijing, and other BCAMS study members and participants for their continuing participation in this research effort.

Funding

This work was supported by grants from the National Key Research Program of China (2016YFC1304801), National Natural Science Foundation of China (81970732), the Capital’s Funds for Health Improvement and Research (2020-2Z-40117), Beijing Natural Science Foundation (7172169), key program of Beijing Municipal Science & Technology Commission (D111100000611001, D111100000611002), Beijing Science & Technology Star Program (2004A027), Novo Nordisk Union Diabetes Research Talent Fund (2011A002), National Key Program of Clinical Science (WBYZ2011-873), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT32001), and AMS Innovation Fund for Medical Sciences (CIFMS 2021-1-I2M-016).

Author information

Authors and Affiliations

Authors

Contributions

GL contributed to the data analysis and drafted the manuscript; LZ performed data analyses and edited the manuscript; LH, YW, BL, DW, YL, and QZ contributed to data collection; YZ contributed to the data interpretation; QL, JRS and SMW contributed to the data interpretation and edited/ revised the manuscript; ML contributed to the concept, design of the study, analyzed the data and revised the manuscript. SG was responsible for the concept, design, and data collection in the BCAMS follow-up study, and contributed to the acquisition and interpretation of the data, and revised the manuscript.

Corresponding authors

Correspondence to Ming Li or Shan Gao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study was approved by the local ethics committee and is following the declaration of Helsinki on ethical principles for medical research involving human participants. Written informed consent was obtained from all patients before participation in this study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, G., Zhong, L., Han, L. et al. Genetic variations in adiponectin levels and dietary patterns on metabolic health among children with normal weight versus obesity: the BCAMS study. Int J Obes 46, 325–332 (2022). https://doi.org/10.1038/s41366-021-01004-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-021-01004-z

This article is cited by

Search

Quick links